Arkolith/Insider Trading/GALT/Form 4

Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$33K
Net Open-Market Flow
-$33K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)8K$1.23$10K8K
Dec 31, 2025Sell(S)8K$4.07$33K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)8K—$041K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML